Evaluation of disc diffusion methods and Vitek 2 automated system for testing susceptibility to mupirocin in Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 62, Issue 5, 2008, Pages 1018-1023

  Malaviolle, Xavier ^a   Nonhoff, Claire ^a   Denis, Olivier ^a   Rottiers, Sylvianne ^a   Struelens, Marc J ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

Low level resistance; MRSA; Mupirocin resistance; Topical decolonization therapy

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL PROTEIN; METICILLIN; PROTEIN MUPA; PSEUDOMONIC ACID; UNCLASSIFIED DRUG;

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOANALYSIS; BACTERIAL STRAIN; BACTERIUM ISOLATION; CONTROLLED STUDY; DISK DIFFUSION; DRUG DETERMINATION; DRUG SCREENING; INTERMETHOD COMPARISON; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIOLOGICAL TECHNIQUES; DNA, BACTERIAL; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MUPIROCIN; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS;

EID: 54549110286     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkn345     Document Type: Article

References (26)

1. Harbarth S, Liassine N, Dharan S et al. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2000; 31: 1380-5.
2. Boyce JM. MRSA patients: Proven methods to treat colonization and infection. J Hosp Infect 2001; 48 (Suppl. A): S9-S14.
3. Jones JC, Rogers TJ, Brookmeyer P et al. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis 2007; 45 541-7.
4. Laupland KB, Conly JM. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: An evidence-based review. Clin Infect Dis 2003; 37 933-8.
5. Anon. Mupirocin-resistant Staphylococcus aureus. Lancet 1987; ii: 387-8.
6. Yang JA, Park DW, Sohn JW et al. Molecular analysis of isoleucyl-tRNA synthetase mutations in clinical isolates of methicillin-resistant Staphylococcus aureus with low-level mupirocin resistance. J Korean Med Sci 2006; 21: 827-32.
7. Woodford N, Watson AP, Patel S et al. Heterogeneous location of the mupA high-level mupirocin resistance gene in Staphylococcus aureus. J Med Microbiol 1998; 47: 829-35.
8. Udo EE, Jacob LE, Mathew B. Genetic analysis of methicillin-resistant Staphylococcus aureus expressing high- and low-level mupirocin resistance. J Med Microbiol 2001; 50: 909-15.
9. Hudson IR. The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: A review of recent experience. J Hosp Infect 1994; 27: 81-98.
10. Harbarth S, Dharan S, Liassine N et al. Randomized, placebo-controlled, double-blind trial to evaluate the efficacy of mupirocin for eradicating carriage of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1999; 43: 1412-6.
11. Fuchs PC, Jones RN, Barry AL. Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic. J Clin Microbiol 1990; 28: 608-9.
12. Eigner U, Schmid A, Wild U et al. Analysis of the comparative workflow and performance characteristics of the VITEK 2 and Phoenix systems. J Clin Microbiol 2005; 43: 3829-34.
13. Denis O, Deplano A, Nonhoff C et al. In vitro activities of ceftobiprole, tigecycline, daptomycin, and 19 other antimicrobials against methicillin-resistant Staphylococcus aureus strains from a national survey of Belgian hospitals. Antimicrob Agents Chemother 2006; 50: 2680-5.
14. Denis O, Deplano A, Nonhoff C et al. National surveillance of methicillin-resistant Staphylococcus aureus in Belgian hospitals indicates rapid diversification of epidemic clones. Antimicrob Agents Chemother 2004; 48: 3625-9.
15. Maes N, Magdalena J, Rottiers S et al. Evaluation of a triplex PCR assay to discriminate Staphylococcus aureus from coagulase-negative staphylococci and determine methicillin resistance from blood cultures. J Clin Microbiol 2002; 40: 1514-7.
16. Creagh S, Lucey B. Interpretive criteria for mupirocin susceptibility testing of Staphylococcus spp. using CLSI guidelines. Br J Biomed Sci 2007; 64: 1-5.
17. Andrews JM. BSAC standardized disc susceptibility testing method (version 5). J Antimicrob Chemother 2006; 58: 511-29.
18. Ramsey MA, Bradley SF, Kauffman CA et al. Identification of chromosomal location of mupA gene, encoding low-level mupirocin resistance in staphylococcal isolates. Antimicrob Agents Chemother 1996; 40: 2820-3.
19. Boyce JM. Preventing staphylococcal infections by eradicating nasal carriage of Staphylococcus aureus: Proceeding with caution. Infect Control Hosp Epidemiol 1996; 17: 775-9.
20. Upton A, Lang S, Heffernan H. Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance. J Antimicrob Chemother 2003; 51: 613-7.
21. Denis O, Deplano A, De Ryck R et al. Emergence and spread of gentamicin-susceptible strains of methicillin-resistant Staphylococcus aureus in Belgian hospitals. Microb Drug Resist 2003; 9: 61-71.
22. Walker ES, Vasquez JE, Dula R et al. Mupirocin-resistant, methicillin-resistant Staphylococcus aureus: Does mupirocin remain effective? Infect Control Hosp Epidemiol 2003; 24: 342-6.
23. Gemmell CG, Edwards DI, Fraise AP et al. Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK. J Antimicrob Chemother 2006; 57: 589-608.
24. Finlay JE, Miller LA, Poupard JA. Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob Agents Chemother 1997; 41: 1137-9.
25. Palepou MF, Johnson AP, Cookson BD et al. Evaluation of disc diffusion and Etest for determining the susceptibility of Staphylococcus aureus to mupirocin. J Antimicrob Chemother 1998; 42: 577-83.
26. de Oliveira NE, Cardozo AP, Marques EA et al. Interpretive criteria to differentiate low- and high-level mupirocin resistance in Staphylococcus aureus. J Med Microbiol 2007; 56: 937-9.